33
/es/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
August 1, 2025
7975116
757069
2

1 ene 2007 año - Food and Drug Administration Amendments Act of 2007

Descripción:

Specifically authorized FDA to require manufacturers post-marketing clinical studies to monitor for risks infected during the pre-market approval process
Also required REMS programs where necessary. What is a REMS program?

Añadido al timeline:

fecha:

1 ene 2007 año
Ahora mismo
~ 18 years ago